Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

2
Player Avatar alaskiian (< 20) Submitted: 2/12/2010 12:08:08 PM : Outperform Start Price: $4.95 PCYC Score: +1,928.11

Well....back in 2000 hit 80.00....undervalued...4star watch...i'm in!!!

Featured Broker Partners


Advertisement